Literature DB >> 32729095

Procyanidins exhibits neuroprotective activities against cerebral ischemia reperfusion injury by inhibiting TLR4-NLRP3 inflammasome signal pathway.

Bo Yang1,2, Yanxia Sun3, Chunchao Lv2, Wei Zhang4, Yizhao Chen5,6.   

Abstract

BACKGROUND: Ischemic stroke is a serious cardiovascular disease with high morbidity and mortality rates that affects millions of people worldwide.Currently, the only therapy with proven efficacy for acute ischemic stroke is alteplase, however, it still has many shortcomings and limitations. Therefore,we screen new compounds from traditional Chinese medicine to explore their efficacy against ischemic reperfusion injury. Procyanidins, a natural productextracted from grapes seed, which have been shown can ameliorate cerebral ischemic injury. However, the underlying mechanism is still not very clear. Theaim of this study was to investigate the effect of procyanidins on middle cerebral artery occlusion/reperfusion (MCAO/R)-mediated cerebral ischemic injuryand its underlying possible mechanisms.
METHODS: SD rats were used to evaluate the effect of procyanidins on MCAO/R induced cerebral ischemic injury in vivo. Histological analysis was used toassess neuronal apoptosis. Cell signaling was assayed by Western blot.
RESULTS: In this study, we found that procyanidins can significantly ameliorate the middle cerebral artery occlusion/reperfusion (MCAO/R)-mediatedneurological deficits, and relieved brain edema, cerebral infarction volume, histopathological damage and apoptosis in rats. In addition, procyanidins canalso markedly inhibit MCAO/R and oxygen-glucose deprivation/reoxygenation (OGD/R)-mediated activation of TLR4-p38-NF-κB-NLRP3 signalingpathway in vitro and in vivo. Moreover, procyanidins can inhibit MCAO/R and OGD/R-induced the production of inflammatory cytokines such asinterleukin-1β (IL-1β) in vitro and in vivo. Besides, treatment with TLR4 inhibitor (Cli-095) in BV2 cell also shows the same effect.
CONCLUSION: Altogether, these data suggested that procyanidins exerted a potential neuroprotective effect may by inhibit the TLR4-p38-NF-κB-NLRP3signaling pathway in the brain in MCAO/R rats.

Entities:  

Keywords:  Ischemic stroke; MCAO/R; NLRP3 inflammasome; OGD/R; Procyanidins; TLR4

Year:  2020        PMID: 32729095     DOI: 10.1007/s00213-020-05610-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  10 in total

Review 1.  Polyphenols for the Treatment of Ischemic Stroke: New Applications and Insights.

Authors:  Shuhan Liu; Feng Lin; Jian Wang; Xiaoqiang Pan; Liguang Sun; Wei Wu
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

Review 2.  The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke.

Authors:  Xing-Hua Li; Feng-Ting Yin; Xiao-Hang Zhou; Ai-Hua Zhang; Hui Sun; Guang-Li Yan; Xi-Jun Wang
Journal:  Molecules       Date:  2022-05-12       Impact factor: 4.927

3.  PAF Receptor Inhibition Attenuates Neuronal Pyroptosis in Cerebral Ischemia/Reperfusion Injury.

Authors:  Bo Zhao; Yuxiang Fei; Jianping Zhu; Qiyang Yin; Weirong Fang; Yunman Li
Journal:  Mol Neurobiol       Date:  2021-09-25       Impact factor: 5.590

Review 4.  Oxidative Stress, Inflammation, and Autophagy: Potential Targets of Mesenchymal Stem Cells-Based Therapies in Ischemic Stroke.

Authors:  Jialin He; Jianyang Liu; Yan Huang; Xiangqi Tang; Han Xiao; Zhiping Hu
Journal:  Front Neurosci       Date:  2021-02-26       Impact factor: 4.677

Review 5.  The Influence of Mitochondrial-DNA-Driven Inflammation Pathways on Macrophage Polarization: A New Perspective for Targeted Immunometabolic Therapy in Cerebral Ischemia-Reperfusion Injury.

Authors:  Sihang Yu; Jiaying Fu; Jian Wang; Yuanxin Zhao; Buhan Liu; Jiahang Wei; Xiaoyu Yan; Jing Su
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

Review 6.  NLRP3: Role in ischemia/reperfusion injuries.

Authors:  Soudeh Ghafouri-Fard; Hamed Shoorei; Yadollah Poornajaf; Bashdar Mahmud Hussen; Yasaman Hajiesmaeili; Atefe Abak; Mohammad Taheri; Ahmad Eghbali
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

Review 7.  Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.

Authors:  Qingxue Xu; Bo Zhao; Yingze Ye; Yina Li; Yonggang Zhang; Xiaoxing Xiong; Lijuan Gu
Journal:  J Neuroinflammation       Date:  2021-05-31       Impact factor: 8.322

8.  Vinpocetine Attenuates Ischemic Stroke Through Inhibiting NLRP3 Inflammasome Expression in Mice.

Authors:  Dong Han; Jue Wang; Lulu Wen; Miao Sun; Hang Liu; Yan Gao
Journal:  J Cardiovasc Pharmacol       Date:  2020-12-22       Impact factor: 3.271

9.  Punicalin Alleviates OGD/R-Triggered Cell Injury via TGF-β-Mediated Oxidative Stress and Cell Cycle in Neuroblastoma Cells SH-SY5Y.

Authors:  Tiansong Yang; Qingyong Wang; Yuanyuan Qu; Yan Liu; Chuwen Feng; Yulin Wang; Weibo Sun; Zhongren Sun; Yulan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-02-12       Impact factor: 2.629

Review 10.  Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury.

Authors:  Ping Huang; Haitong Wan; Chongyu Shao; Chang Li; Ling Zhang; Yu He
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.